The Skin Perfusion Pressure Testing Devices Market is gaining increasing importance in modern vascular diagnostics, driven by the growing prevalence of peripheral arterial disease (PAD), diabetes-related complications, and chronic wounds. Skin perfusion pressure (SPP) testing provides a non-invasive and quantitative assessment of microcirculatory blood flow, enabling clinicians to evaluate tissue viability and predict wound healing potential. In 2024, the market was valued at US$ 1,851.6 million and is projected to expand at a robust CAGR of 9.60% from 2025 to 2032, reflecting rising clinical adoption and technological advancements.
Market Overview and Growth Drivers
Skin perfusion pressure testing devices are widely used to assess lower-limb ischemia, particularly in patients with diabetes, critical limb ischemia, and non-healing ulcers. Unlike traditional diagnostic methods, SPP testing offers localized, reliable measurements of tissue perfusion, supporting accurate clinical decision-making.